# Veradigm (MDRX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/MDRX
## Company Profile
- Ticker: MDRX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 5 USD
- Market cap: Not available USD
- Last updated: 2026-10-08
## Business Overview
Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.
## Why The Stock Is Moving

As of Oct 8, 2026, MDRX was little changed and closed at $5.00. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Veradigm sits in healthcare IT.

## Business Model

Revenue depends on software subscriptions, data products, and the commercialization of workflow tools across healthcare users.

## Landscape Position

Veradigm is outside biotech and belongs to the healthcare information layer, where software adoption and execution matter most.

## Future Catalysts

- Veradigm's catalysts are claims-data products, payer and life-science software demand, and any operating update that clarifies the turnaround path. The company is still a software-and-data execution story.

## Recent News
- 2026-09-08 12:00 EST — [Veradigm Announces Updated Presentation Time for Upcoming Investor Conference](https://biopharmsignal.com/news/MDRX/veradigm-announces-updated-presentation-time-for-upcoming-investor-conference-b5daba96) — Source: Veradigm
- 2026-08-17 12:01 EST — [Veradigm to Participate in Two Upcoming Investor Conferences](https://biopharmsignal.com/news/MDRX/veradigm-to-participate-in-two-upcoming-investor-conferences-f6ac76a6) — Source: Veradigm
- 2026-05-26 20:10 EST — [Veradigm Files 2023 and 2024 Form 10-K](https://biopharmsignal.com/news/MDRX/veradigm-files-2023-and-2024-form-10-k) — Source: Veradigm
- 2026-05-26 12:01 EST — [Veradigm to Release Business Update May 26th and Host Investor Call May 27th](https://biopharmsignal.com/news/MDRX/veradigm-to-release-business-update-may-26th-and-host-investor-call-may-27th) — Source: Veradigm
- 2026-05-06 20:01 EST — [Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices](https://biopharmsignal.com/news/MDRX/veradigm-launches-health-network-architecture-to-level-the-playing-field-for-independent-practices) — Source: Veradigm